In summary, our study sheds light on the pathophysiological importance of Drp1 variant expression and their ability to modify mitochondrial fission and fusion dynamics as a novel mechanism underlying ovarian cancer cell plasticity. This evidence concerns the gene DNM1L and ovarian cancer.